Henry Schein Inc (HSIC)
Henry Schein Inc (HSIC) is a global provider of healthcare products and services, primarily serving dental, medical, and veterinary practitioners. The company offers dental equipment, consumables, pharmaceuticals, and technology solutions, supporting healthcare professionals in delivering quality patient care. Established in 1932, Henry Schein has built a reputation as a comprehensive distributor and service provider in the healthcare industry.
Company News
Entrepreneur William Brooke Webb Jr. alleges that Henry Schein employee secretly opened a competing lab and sabotaged his business, leading to a two-volume book exposing corruption in the Oklahoma medical laboratory industry.
Henry Schein reported strong Q3 earnings, beating consensus estimates with $1.38 adjusted earnings per share and $3.34 billion in sales. The company expanded its strategic partnership with KKR and raised its fiscal 2025 guidance for earnings and sales.
Healthcare solutions distributor Henry Schein reported Q2 2025 financial results with mixed performance, experiencing revenue growth but declining profitability due to margin pressures in dental operations and increased restructuring costs.
Here we discuss four stocks from the Dental Supplies industry that are likely to earn wealth for investors. These include MCK, WST, ALGN and HSIC.
Henry Schein Inc.’s stock fell 3% early Tuesday, after the provider of dental and medical supplies’ fourth-quarter earnings came in short of expectations, hurt by higher-than-usual acquisition-related costs and the continued impact of a cyberattack in 2023.
Related Companies
